Fitbeing Pharmaceuticals Private Limited
Founded in 2019 and headquartered in Uttar Pradesh, India.
2019 | Etawah, Uttar Pradesh (India) | Active
Fitbeing Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth -25.55%
- Ebitda -7.06%
- Net Worth -23.59%
- Total Assets -0.68%
About Fitbeing Pharmaceuticals
Fitbeing Pharmaceuticals Private Limited (FPPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 May 2019 (Five years and nine months 21 days old ). Its registered office is in Etawah, Uttar Pradesh, India.
The Company is engaged in the Veterinary Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rohitesh Singh and Kavita serve as directors at the Company.
Company Details
- Location
Etawah, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85200UP2019PTC116787
- Company No.
116787
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 May 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Veterinary
Who are the key members and board of directors at Fitbeing Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohitesh Singh  | Managing Director | 10-May-2019 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kavita | Director | 10-May-2019 | Current |
Financial Performance of Fitbeing Pharmaceuticals.
Fitbeing Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 25.55% decrease in profit. The company's net worth observed a substantial decline by a decrease of 23.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fitbeing Pharmaceuticals?
Unlock access to Fitbeing Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Fitbeing Pharmaceuticals?
Unlock and access historical data on people associated with Fitbeing Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fitbeing Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fitbeing Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.